NFKB1 and familial dilated cardiomyopathy: The findings of present study reinforced the defensive role of 6b against inflammation, oxidative stress, apoptosis, hypertrophy and fibrosis both in vitro and in vivo and further suggested that NF‐κB and Nrf2 may be promising therapeutic targets for treating DCM.